Global Hemostatic Powder Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Hemostatic Powder Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.
Hemostat powder is product in form of powder.
Hemostatic Powder report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hemostatic Powder market is projected to reach US$ 480.6 million in 2034, increasing from US$ 386.4 million in 2022, with the CAGR of 3.1% during the period of 2024 to 2034. Demand from Hospital and Clinics are the major drivers for the industry.
Market competition is intense. Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring and Gelita Medical, etc. are the leaders of the industry, with about 70% market shares.
North America is the largest consumption place, with a consumption market share nearly 40%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
The classification of hemostat powder includes gelatin, fibrin, cellulose and the proportion of gelatin is about 38%.
Hemostat Powder is widely used in surgical wound care and general wound care. The most proportion of hemostat powder is used in surgical wound care, and the proportion is 66%.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hemostatic Powder market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
Johnson & Johnson
BD
Baxter
B.Braun
Cura Medical
GELITA MEDICAL
Curasan AG
Meril Life Sciences
Zhonghui Shengxi
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Beijing Taikesiman
Foryou Medical
Saikesaisi Holdings Group
Biotemed
Segment by Type
Absorbable Hemostatic Agent
Not Absorbable Hemostatic Agent
Hospital
Clinics
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hemostatic Powder market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hemostatic Powder, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hemostatic Powder industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Hemostatic Powder in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hemostatic Powder introduction, etc. Hemostatic Powder Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Hemostatic Powder market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.![](http://localhost/mraccuracy/images/About Report.webp)
Hemostat powder is product in form of powder.
Hemostatic Powder report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hemostatic Powder market is projected to reach US$ 480.6 million in 2034, increasing from US$ 386.4 million in 2022, with the CAGR of 3.1% during the period of 2024 to 2034. Demand from Hospital and Clinics are the major drivers for the industry.
Market competition is intense. Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring and Gelita Medical, etc. are the leaders of the industry, with about 70% market shares.
North America is the largest consumption place, with a consumption market share nearly 40%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
The classification of hemostat powder includes gelatin, fibrin, cellulose and the proportion of gelatin is about 38%.
Hemostat Powder is widely used in surgical wound care and general wound care. The most proportion of hemostat powder is used in surgical wound care, and the proportion is 66%.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hemostatic Powder market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
By Company
Johnson & Johnson
BD
Baxter
B.Braun
Cura Medical
GELITA MEDICAL
Curasan AG
Meril Life Sciences
Zhonghui Shengxi
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Beijing Taikesiman
Foryou Medical
Saikesaisi Holdings Group
Biotemed
Segment by Type
Absorbable Hemostatic Agent
Not Absorbable Hemostatic Agent
Segment by Application
Hospital
Clinics
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hemostatic Powder market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hemostatic Powder, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hemostatic Powder industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Hemostatic Powder in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hemostatic Powder introduction, etc. Hemostatic Powder Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Hemostatic Powder market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
![](http://localhost/mraccuracy/images/About Report.webp)